Financial Analyst - Newark, CA | Biospace
Get Our FREE Industry eNewsletter

Financial Analyst

Depomed, Inc.

Apply
Location:
Newark, CA
Posted Date:
7/27/2017
Position Type:
Full time
Job Code:
973XX
Salary:
Required Education:
Bachelors Degree
Areas of Expertise Desired:

Job Description

City Newark
State California [CA]
Title Financial Analyst
Job ID 973XX
Date Added 7/5/2017
Department Finance

Description

The Financial Analyst reports to Associate Director, Finance, as part of the FP&A team. The role will require the analyst to work closely with Accounting, Commercial Departments, and other functional areas within the Company, primarily responsible for Sales organization and allocations FP&A, and other corporate needs including inventory and royalty accounting support.

ESSENTIAL JOB FUNCTIONS
-Sales Organization and Allocations Departments financial support:
•Assist in Sales departmental budgets and forecasts, including template preparation, run rate calculations, and ad hoc analysis to support budget submissions
•Forecast internal allocations based on run rate and budget proposals from departments, prepare allocation department budget and reforecasts.
•Manage monthly financial close process for departments, including accruals and expense estimates, proactively meeting with budget owners to ensure accurate expense recording
•Responsible for audit requests related to Sales departments, including proper documentation and compliance to internal SOX control
•Prepare and distribute monthly Actual vs. Budget reports for Sales and Allocation departments, spend by vendor analysis, and other monthly reporting needs
•Approve of department purchase orders - determining within budget and respective account coding
•Invoice validation and tracking of open purchase orders

-Corporate FP&A needs, including but not limited to
•Inventory accounting support
•Prepare royalty calculations, journal entries and sales reports/certifications for incoming and outgoing royalties and milestones
•Prepare and distribute analyst report summary
•Other month end, audit, and planning support
•Ad-hoc analysis for corporate and commercial team

ADDITIONAL RESPONSIBILITIES/DUTIES
•Develop strong cross-functional working relationships with the Commercial departmental heads

Requirements

EDUCATION AND EXPERIENCE
•Bachelor’s Degree
•0-3 years Finance or Accounting experience
•Strong Analytical Skills

SKILLS AND ABILITIES
•Strong mathematical intuition
•Advanced excel
•Financial modeling capabilities
•Strong multi-tasking
•Ability to learn in fast paced environment

DEPOMED COMPETENCIES INCLUDE
•Integrity
•Ownership & Initiative
•Decisions & Judgment
•Adaptability & Change Readiness
•Teamwork & Collaboration

PHYSICAL/MENTAL DEMANDS
•Sitting
•Standing/ walking
•Repetitive motion: computer usage
•Visual Requirements: computer usage

About Us

Depomed, Inc. is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. Founded in 1995, Depomed has successfully executed on strategy of acquiring, integrating and growing differentiated therapeutic products and building each into a strong market presence. The result is a broad portfolio of pain and neurology specialty pharmaceuticals currently comprised of five FDA-approved products. These include Gralise® for the management of Postherpetic Neuralgia (PHN), Cambia® for the acute treatment of migraine attacks, Zipsor® for the relief of mild to moderate acute pain, Lazanda® for the management of breakthrough pain in cancer patients and our most recent addition, the company’s flagship asset, the NUCYNTA® franchise.

Acquired in April 2015 and re-launched in June 2015, the NUCYNTA franchise includes NUCYNTA® ER for the extended management of pain, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) and NUCYNTA® for immediate management of moderate to severe acute pain in adults.


Depomed also has successfully developed and licensed its unique drug-delivery technology, Acuform®. This patented oral-delivery technology allows for the targeted, extended release of pharmaceutical compounds into the upper gastrointestinal tract. The company’s Acuform technology is currently being used in four marketed drugs, including Gralise.

Depomed’s successful execution on strategy and has resulted in solid product revenue growth over the past three years. Located in Newark, California in the East Bay of San Francisco, Depomed is listed on the NASDAQ market under the ticker DEPO and employs approximately 500 people, of which approximately 350 are part of the Commercial organization.